Albemarle Corporation (ALB)

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Dividend Aristocrats have underperformed the S&P 500 in 2025, with NOBL up 1.77% versus SPY's 5.55% year-to-date gain. Dividend growth remains healthy, with 44 out of 69 Aristocrats already raising pa...

Albemarle (ALB) concluded the recent trading session at $64.95, signifying a +1.88% move from its prior day's close.

Albemarle (ALB) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Five of the ten lowest-priced S&P 500 Dividend Aristocrats are currently attractive buys, offering high yields and fair valuations for income investors. Analyst forecasts suggest potential net gains o...

We Initiate Albemarle at Strong Buy, $125 PT, citing deep undervaluation and robust volume growth from project ramps and cost discipline. ALB's volume-led strategy, contract coverage, and supply chain...

Most retail investors fall to the default belief that they do not have any competitive advantage compared to the world of hedge funds and investment banks, otherwise known as the smart money instituti...

Albemarle's stock performance is closely tied to lithium prices, with EV demand and alternative minerals influencing future prospects. The company's financials show solid revenue and cost management, ...

Soft demand in specific markets and the sluggishness in China and Europe pose headwinds for the Zacks Chemicals Diversified industry. DD, ALB and KRO are poised to navigate the industry challenges.

In the most recent trading session, Albemarle (ALB) closed at $65.08, indicating a +1.37% shift from the previous trading day.